# TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tlr4-antagonist-reduces-early-stage-atherosclerosis-in-diabetic-apolipoprotein-e/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zhongyang Lu,Xiaoming Zhang,Yanchun Li,Junfei Jin,Yan Huang |
| Citations | 78 |
| DOI | 10.1530/joe-12-0338 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://joe.bioscientifica.com/downloadpdf/journals/joe/216/1/61.pdf |
| OpenAlex ID | https://openalex.org/W2111410554 |
| PMID | 23060524 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Junfei Jin](https://scholariq.org/researchers/junfei-jin/)

## Paper primary topic

- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)

## Paper topics

- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)
- [Atherosclerosis and Cardiovascular Diseases](https://scholariq.org/topics/atherosclerosis-and-cardiovascular-diseases/)
- [Immune Response and Inflammation](https://scholariq.org/topics/immune-response-and-inflammation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.